webinar register page

22nd Annual Frontiers in Diabetes Research Conference: Obesity, Diabetes and COVID-19: Elucidating Bidirectional Links - 11/21/20 (10 AM - 3:00 PM EST)
This virtual half-day program is designed for research scientists, clinicians, and students with an interest in diabetes and obesity.

Specifically, this conference will focus on recent clinical and basic insights regarding SARS-CoV2 infection. Particular emphasis will be placed on the potential metabolic/genetic and demographic links to susceptibility and clinical outcomes in patients with obesity and pre-existing diabetes. Additional areas of focus will include novel treatment paradigms for diabetes in the COVID-19 era, and a look forward towards novel antiviral therapies.

At the conclusion of this activity, participants will be better able to:

Review epidemiology, pathogenesis, and current/future treatment paradigms for COVID-19.
Discuss obesity and diabetes as risk factors for SARS-CoV2-related patient outcomes.
Discuss management of diabetes and dysmetabolism in patients with COVID-19.

This activity has been approved for AMA PRA Category 1 Credit™

Nov 21, 2020 10:00 AM in Eastern Time (US and Canada)

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.